Authors: AELLIG W BADER JP BASS R BAUMBAUER E BEGLINGER C BRUPPACHER R CARLHANTKOWALSKI D CRUSIUS I GALLAGHER J GALLOTORRES H GELLERT J HULLA F KREMER G KREUTZ G LAMACHE E MANN RD PFEIFFER M REITER C RHODES JM SCHRANK J STEINBACH T VENULET J VILARDELL F

Citation: W. Aellig et al., DEFINITIONS AND BASIC REQUIREMENTS FOR THE USE OF TERMS FOR REPORTINGADVERSE DRUG-REACTIONS (X) - GASTROINTESTINAL SYSTEM DISORDERS, Pharmacoepidemiology and drug safety, 7(4), 1998, pp. 281-287

Authors: AELLIG W BANKOWSKI Z BAUMBAUER E BRUPPACHER R CONE M COVESMITH R DEBRE M EDWARDS IR GALLAGHER J GRABENSEE B IDANPAANHEIKKILA J KREMER G KREUTZ G KRUPP P LESKI M LUMPKIN MM OSTER M PFEIFFER M ROCCO F SAUER F SCHOU J SHRANK J SCHUMANN W SPIEGL W SPINELLI F SPRENGER K TENHAM M TRENQUE T VENULET J WEIDMANN E WEISS JM WOOD KL

Citation: W. Aellig et al., BASIC REQUIREMENTS FOR THE USE OF TERMS FOR REPORTING ADVERSE DRUG-REACTIONS .8. RENAL AND URINARY SYSTEM DISORDERS, Pharmacoepidemiology and drug safety, 6(3), 1997, pp. 203-211

Authors: BAUMBAUER E

Citation: E. Baumbauer, CLINICAL DRUG RESEARCH - POINT-OF-VIEW OF INDUSTRY, Langenbecks Archiv fur Chirurgie, 1996, pp. 646-650